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Soft tissue sarcomas may present with deep
vein thrombosis
Matthew Benns, MD,a Michael Dalsing, MD,b Alan Sawchuck, MD,b and L. Daniel Wurtz, MD,c
Indianapolis, Ind
Purpose: To bring attention to our observation that soft tissue sarcomas may present initially as deep venous thromboses
(DVTs).
Method:A query of our health system database (1996 to 2004) for patients diagnosed with soft tissue sarcomas and DVTs
was undertaken. Patient medical records were reviewed to select those patients whose DVT occurred before the diagnosis
of their tumor. Patient demographics, tumor classification, presentation, and outcome were noted.
Results: Six of 19 patients were identified (four men, two women; aged 41 to 85 years). All tumors occurred in the lower
extremities. All DVTs occurred in the same extremity as the tumor. Pathology specimens indicated four different types of
sarcomas. In five cases, sarcoma diagnosis was delayed as treatment of the DVT occurred. In one, a mass was seen on the
initial venous duplex screen. Four are deceased, one remains in treatment, and one was lost to follow-up. The average
length of follow-up was 10 months.
Conclusion: Soft tissue sarcomas can initially present as, or even be misdiagnosed as, DVT. Given a delay in diagnosis
adversely affects prognosis, it is important that physicians be vigilante for associated tumors when evaluating for
suspected DVT. (J Vasc Surg 2006;43:788-93.)Soft tissue sarcoma is a serious and potentially fatal
neoplastic disease characterized by local extension and oc-
casional distant metastasis. Depending on tumor size and
location, resection can prove to be a challenging problem.
In addition, recurrence after resection for many types of
soft tissue sarcoma frequently will occur. For these reasons,
prompt diagnosis and appropriate management of soft
tissue sarcoma is essential to minimize morbidity and mor-
tality.
This retrospective study was undertaken after a clinical
observation suggested an association between the presence
of lower-extremity sarcoma and a diagnosis of deep venous
thrombosis (DVT). From our experience, it appeared that
DVT could represent a potential pitfall in the early diagno-
sis of soft tissue sarcoma. The ultimate goal is to present our
findings to increase the awareness that patients presenting
with symptoms of DVT may be hiding a more sinister
diagnosis.
METHODS
A database of patient medical information from our
institution, which includes two large tertiary referral cen-
ters, is fully maintained dating back to 1996. This database
was queried for all patients during an 8-year period (1996
to 2004)with the diagnoses of both sarcoma and deep venous
thrombosis (International Classification of Diseases, 9th revi-
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788sion, 451, 171). Medical records were examined to isolate
those patientswhoseDVTwas diagnosed before the diagnosis
of the sarcoma. Demographic information, clinical presen-
tation, diagnostic methods, interventions, and outcome
were determined from the information contained in the
electronic database and by patient chart review. The study
as designed and undertaken met our institutional review
board guidelines and process.
The initial presentation and diagnostic procedures
(most commonly a venous duplex) occurred at an outside
hospital or private physician office for many of the patients.
Patients were referred to our institution after failure of an
initial treatment plan or after suspicion that a malignant
process might be a component of the patient’s problems.
RESULTS
During the time period, 5234 patients were treated for
soft tissue sarcoma and 6241 patients were treated for DVT
at our institution, and 19 patients had a medical history of
both soft tissue sarcoma and DVT (0.36% of sarcoma
patients). Among these patients, six (0.11%) were identified
whose DVT was diagnosed before their soft tissue sarcoma.
Four of the patients were referred for failure of an initial
treatment plan, and the remaining two, on suspicion of
malignancy.Men outnumbered women by a 2:1 ratio; their
median age was 49 years (range, 41 to 85).
Four different types of soft tissue sarcomas were repre-
sented. All tumors occurred in the lower extremities; the
thigh was the most common location (Table I). The initial
diagnosis of DVT was made with venous duplex ultra-
sonography scans in all subjects. The average delay between
the diagnosis of DVT and the ultimate diagnosis of the soft
tissue sarcoma was 3.6 months (range, 0 to 12 months)
(Table II).
rcom
n
JOURNAL OF VASCULAR SURGERY
Volume 43, Number 4 Benns et al 789Patient 1 was a 63-year-old man who presented to an
outside hospital with complaints of increasing pain and
swelling in his left thigh. He was admitted to the hospital,
diagnosed with DVT by a duplex ultrasonography exami-
nation, and prescribed anticoagulation therapy, beginning
with intravenous heparin. On hospital day 1, a large hema-
toma developed on his left thigh. He was taken to the
operating room for hematoma evacuation. A pathology
analysis of the evacuated blood clots revealed tumor frag-
ments of a malignant fibrous histiocytoma.
The patient was transferred to our facility for further
evaluation and management. There was no evidence of
distant metastasis at presentation, and the patient under-
went initially successful resection. Less than 2 years later,
however, the patient developed local recurrence and distant
metastases to the lung, spine, and liver. Despite further
surgical resection and chemotherapy, the patient ultimately
died from his disease.
Patient 2 was a 49-year-old man who developed acute
shortness of breath postoperatively after a colostomy revi-
sion initially performed for diverticular disease. He was
found to have a pulmonary embolus by spiral computed
tomography (CT) scan and DVT in the left femoral vein by
duplex ultrasonography scan. He was treated with antico-
agulation and released from the hospital, but complained of
persistent pain in the left thigh.
After seven months, a CT scan of the leg showed a left
thigh mass with involvement of the superficial femoral
artery and femoral vein (Fig 1). There was no evidence of
distant metastasis, and the patient underwent resection that
included arterial bypass and femoral vein resection. The
patient was treated at our institution for a period of 12
months before being lost to follow-up.
Patient 3 was an 85-year-old woman who had experi-
Table I. Patient demographics and tumor characteristics
Patient Age Sex (M, F) Tum
1 63 M Malignant
2 50 M Pleomorph
3 85 F Malignant
4 70 M Malignant
5 41 F High-grad
6 42 M Leiomyosa
Table II. Delay in diagnosis, treatment, and outcome of l
deep venous thrombosis
Patient
Delay in
diagnosis
Distant metastases
at diagnosis? Initial treatm
1 1 day No Resection, radiatio
2 7 months No Resection/bypass,
3 0 Yes Chemotherapy
4 2 weeks No Resection, radiatio
5 2 months No Resection, radiatio
6 12 months No Resection, radiatioenced 4 months of progressive pain in her right lower thighand knee. She was initially evaluated by an outside physician
who had recommended total knee replacement, which the
patient declined. She was then referred to the orthopedics
service at our facility. A duplex ultrasonography examina-
tion revealed a hypoechoic mass of the medial right thigh,
with thrombosis of the femoral vein proximal to the mass.
Further evaluation revealed extensive pulmonary metasta-
ses. The patient underwent treatment with chemotherapy,
but died from her disease shortly thereafter.
Patient 4 was a 70-year-old man with a history of
peripheral vascular disease who had previously undergone a
right femoral-to-anterior tibial artery bypass with a polytet-
rafluoroethylene (PTFE) graft and a femoral artery pseudo-
aneurysm repair. The patient presented to an outside hos-
pital with a 4-month history of pain behind the right knee.
Venous duplex ultrasonography scanning revealedDVTs of
the femoral and popliteal veins. Magnetic resonance imag-
ing (MRI) demonstrated a popliteal mass thought to be
consistent with a thrombosed and infected popliteal artery
aneurysm.
The patient was started on anticoagulation therapy
with intravenous heparin, intravenous antibiotics, and was
transferred to our facility for further evaluation and treat-
ment. After nearly 2 weeks of therapy, the patient still had
considerable knee pain. ACT scan showed a larger popliteal
mass with ring enhancement. Fine needle aspiration of the
mass yielded a diagnosis of a malignant fibrous histiocy-
toma (Table II). Further evaluation revealed an absence of
distant metastasis, but a repeated lower-extremity MRI
study demonstrated an enlarging tumor extending from
below the lesser tuberosity of the femur into the soft tissues
behind the tibia. The patient underwent right hip disartic-
ulation and subsequent radiation therapy. He was dis-
charged to a rehabilitation facility, but ultimately died from
ssification Location Size
s histiocytoma Left thigh 5 cm
coma Left thigh 5 cm
s histiocytoma Right mid thigh 5 cm
s histiocytoma Right popliteal fossa 5 cm
iosarcoma Right hip/thigh 5 cm
a Left thigh 5 cm
extremity soft tissues sarcomas initially diagnosed as
Length of follow-up
(months) Recurrence? Outcome
28 Local, distant Deceased
tion 12 Unknown Lost to follow-up
1 No Deceased
1 No Deceased
6 No Deceased
12 Distant In treatmentor cla
fibrou
ic sar
fibrou
fibrou
e angower
ent
n
radia
n
nhis disease.
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April 2006790 Benns et alPatient 5 was a 41-year-old woman who initially pre-
sented to her primary care physician with complaints of
right buttock and lower-extremity pain. She was treated
symptomatically, with minimal improvement for 2 months.
She then presented with significant swelling of the right
thigh, which prompted a venous ultrasound study. The
patient was diagnosed with DVT and was prescribed anti-
coagulation therapy.
After 2 months without improvement in pain or swell-
ing, the patient was referred to our facility. CT scans and
MRI revealed hemorrhage in the right gluteus muscles and
an extensive mass deep in the right thigh extending into the
pelvis (Fig 2 A and B). A biopsy specimen of the mass
yielded a diagnosis of a high-grade angiosarcoma. The
patient underwent aggressive surgical therapy, including
hemipelvectomy as well as radiation and chemotherapy.
Unfortunately, she died secondary to septic complications
after approximately 6 months.
Patient 6 is a 42-year-old man who initially presented to
his primary physician with complaints of left lower-extremity
pain and swelling. He was diagnosed with a DVT of his left
femoral vein and placed on anticoagulation therapy. The
patient was continued on therapy for 12 months before
being referred to our facility with complaints of persistent
thigh discomfort and the impression by the patient that the
thigh was increasing in size. Repeat duplex venous ultra-
sonography scans confirmed the presence of DVT and
suggested that a mass was also present. In addition, a mass
was evident on physical examination. This led to a CT scan
Fig 1. Left thigh sarcoma (superior arrthat further characterized a mass of the medial right thigh.A biopsy specimen confirmed the diagnosis of leiomyosar-
coma (Table II). The patient did not have evidence of
distant metastasis on presentation and underwent resection
of his localized tumor. Unfortunately, a pulmonary recur-
rence was discovered after approximately 5 months. The
patient underwent wedge resection and is currently receiv-
ing adjuvant chemotherapy.
DISCUSSION
Soft tissue sarcomas are a heterogeneous group of
tumors composed of more than 50 different histologic
subtypes.1 They have an annual incidence in the United
States of approximately 8680 cases and are associated with
3660 deaths each year.2 The tumors occur most commonly
in the extremities (about 50%).1
Several large series have demonstrated disease-specific
survival rates for extremity soft tissue sarcoma of 73% to
79% at 5 years.3-5 Independent prognostic factors have
been identified and include age 50 years, histologic
grade, tumor size 5 cm, deep vs superficial tumor, prox-
imal vs distal location, and positive microscopic margins on
resection.3-5 Of these factors, high grade and large size are
the primary predictors of mortality.6 This would suggest
that allowing the tumors to grow undetected during treat-
ment for DVTwould not be desirable. In fact, in our study,
all of the patients had a tumor size of 5 cm at the time of
tumor diagnosis (Table I).
Earlier diagnosis would certainly have been preferred
ncasing femoral artery (inferior arrow).for patients in this series. It is unclear, however, how the
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Volume 43, Number 4 Benns et al 791outcome would have been affected if the sarcoma had been
found at the time of DVT diagnosis. Patients 2 and 6 had
significant diagnostic delays (6 months) between their
initial DVT presentation and the diagnosis of sarcoma
(Table II). Patient 2 remained disease free until he was lost
Fig 2. A, Gluteal mass (inferior arrow) with pelvic ext
with marked lower extremity edema.to follow-up at 1 year; however, patient 6 developed pul-monary metastases. Since size 5 cm is a known poor
prognostic factor for both recurrence and overall survival,
these patients clearly would have benefited from earlier
diagnosis. It is possible these tumors were below this size
threshold at the time of their initial DVT diagnosis and
(superior arrow). B, Extension into the thigh (arrow)ensiontreatment.
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per 10,000 people.7 Among newly diagnosed DVT, nearly
40% of patients will not have defined risk factors.7,8 Because
malignancy is a strong risk factor for DVT, the issue of
whether or not patients who present with idiopathic DVT
are harboring an occult malignancy has been well docu-
mented in the literature. Prandoni et al9 found malignancy
in 3.3% of idiopathic DVT patients and in 17.1% of patients
with recurrent DVT. A similar study by Hettiarachchi et
al10 found malignancy in 18% of patients presenting with
DVT. Despite this association, a comprehensive work-up
for malignancy (eg, CT scans, etc.) is not generally indi-
cated for most patients presenting to their primary care
physician with DVT.11 History and physical examination,
routine laboratory studies, and chest radiography are gen-
erally sufficient and cost-effective.11 When physicians do
initiate an aggressive search for malignancy, this will often
include CT imaging of the abdomen and chest to rule out
cancers more commonly associated with DVT (pancreatic,
prostate, etc.). CT scans of the extremity with the DVT are
generally not conducted. Our series showed that only
0.11% of patients with soft tissue sarcoma presented with
DVT. This association seems sufficiently rare not to alter
current practices.
Two other isolated case reports of soft tissue sarcoma
presenting as DVT have been published. The first was that
of a 47-year-old man treated for DVT for 2 years before
the diagnosis of soft tissue sarcoma was made.12 A second
case report described a 27-year-oldwomanwith complaints of
chronic edema and pain of her right leg.13 She was subse-
quently treated for DVT before the ultimate diagnosis of soft
tissue sarcoma. Of note, the patient had CT scans and MRI
of her pelvis early in the course of treatment that failed to
show evidence of malignancy.
CONCLUSION
From the results of our series, we would concur with
Greenwald et al13 that physicians should be aware that soft
tissue sarcoma can present initially as DVT. This should be
kept in mind, particularly in younger patients, those with-
out significant risk factors for DVT, and those with recur-
rent or refractory thrombosis or symptoms. There are no
specific guidelines for extremity imaging (CT or MRI) in
the work-up of DVT, but this could certainly be considered
for unusual patients. To complicate the matter, imaging
may not initially reveal a sarcoma as the cause for DVT, as
was evidenced in the Greenwald case report. This should
also be considered when deciding appropriate follow-up.
The prognostic significance of deep venous thrombosis
with soft tissue sarcoma could not be established with this
me with venous aneurysm that turned out to be primary venoussmall series, but it represents an area of possible future
investigation. The study certainly does confirm that the two
diagnoses can occur in the same patient, and physicians
should keep such an association in mind when they treat
patients who are not typically considered at risk for DVT.
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Dr Peter Gloviczki (Rochester, Minn). I enjoyed your paper
very much. I think it is a very important issue, and maybe because
we are a referral center we see more malignancies, primary or
secondary, than others, but I have had patients who were sent toleiomyosarcoma or simply just DVT. Could you suggest to us an
evaluation algorithm? Are you going to change your algorithm and
include CT scan in all patients with proximal DVT, which we do?
I think any simple deep vein thrombosis where you see even just
minimal enlargement of the veins, where the veins are filled with
JOURNAL OF VASCULAR SURGERY
Volume 43, Number 4 Benns et al 793thrombus, you should be extremely suspicious that that, especially
if it is a large vein like the inferior vena cava, vigilance and biopsy
are required to exclude malignancy.
Dr Benns. I think that is a very good point as far as, well, we
know that this can happen, but what do we do about it as far as
imaging? I think again this is a rare presentation of what is already
a fairly rare disease. I don’t think there is any call for a protocol for
CT scanning of these idiopathic DVTs, because again, the more
common malignancy would be something like pancreatic, and
currently, there aren’t any recommendations to do any abdomen
and pelvis CTs for those patients, so certainly I don’t think you
could make a cause for extremity CTs. However, I think one of the
things that can be done is a more thorough initial physical exami-
nation, because several of our patients in this series had palpable
masses if you looked closely, and I think perhaps that is often
missed with DVT diagnosis. They just base it on ultrasound and
don’t palpate the extremity. Again, if you have an unusual patient
or, like you said, an unusual looking thrombus or someone who is
refractory to treatment, I think certainly at some point you could
consider a CT of the extremity, but it would sort of be based on the
individual patient presentation.
Unidentified doctor. This sort of follows up Peter’s question
a little bit. If I listen carefully to the six cases, it sounded like only
one of the six was diagnosed by ultrasound and duplex, so the
question is, when you looked at the cases were there things that
were missed on duplex? Is there something you can tell us about
duplex that would help make the diagnosis in these cases as you
reviewed them?Dr Benns. Well actually all of the DVTs were diagnosed by
Doppler ultrasound.
Doctor. Tumors. I mean you would think that they could see
some of the tumor at the same time.
Dr Benns. Right. In only I believe one of the cases they
actually saw the hypoechoic mass. The others they did not. Now
whether that dependent on a technician in radiology and they
were there and able to be seen, I don’t know. Most of these
ultrasounds were completed by the primary physicians at the
outside hospitals, so we didn’t have access to any of the actual
images to know whether or not there was something missed, but
that is certainly a possibility and perhaps something that could
be made known to vascular techs and radiologists to sort of be
aware of as well.
Dr Erika Ketteler (Chicago, Ill). I have a question regarding
the treatment of the DVT at the time of the sarcoma resection. Did
the patients get IVC filter placements prior to their sarcoma
removal or did you apply any specific perioperative anticoagulation
regimen?
Dr Benns. To my knowledge, none of the patients received
filter placement. The anticoagulation was discontinued for surgery
and then appropriately begun again postoperatively.
Dr Gloviczki.One final comment. CT angio in patients with
proximal, not paraneoplastic DVT, proximal DVT is extremely
useful. It gives us information on paraneoplastic syndrome. It gives
us information on any potential underlying pathology even if it is
not directly the mechanical cause of the DVT.
